There are no data on the role of TIGIT in MS, but Tigit-overexpressing transgenic mice or mice treated with a TIGIT agonistic antibody had reduced experimental autoimmune encephalomyelitis (EAE) induction, whereas TIGIT-deficient mice were more susceptible to EAE (17). The gene discussed is TIGIT; the disease is myeloid sarcoma.